亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

  • Nanobiotix soars as late-phase cancer trial hits endpoint fiercebiotech
    June 25, 2018
    A phase 2/3 trial of Nanobiotix’s NBTXR3 in soft tissue sarcoma has?met?(PDF) its primary endpoint. The top-line success against the pathological complete response rate endpoint sent Nanobiotix’s stock up by more than 50%.
PharmaSources Customer Service